Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation
Andrew Chi, MD, PhD at NYU Explains Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation.
Author: Cancer-News
Added: 03/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts